VHA-26732-75049
2 vaccinations
2 coded responses
24 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 852 / AZ
- Registered
- 2021-01-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-12
Registered in v-safe
-
2021-01-12
Dose 1 — Pfizer-BioNTech
- 2021-01-12
-
2021-01-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain, Itching · Fever · Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to workAdult check-in
- 2021-01-13
-
2021-01-14
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Itching · Headache, Fatigue or tiredness, Nausea, Vomiting, DiarrheaAdult check-in
-
2021-01-15
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Itching · Fever · Headache, Fatigue or tiredness, NauseaAdult check-in
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-28
- 2021-02-02
-
2021-02-05
Dose 2 — Pfizer-BioNTech
- 2021-02-05
-
2021-02-06
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-02-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-02-08
- 2021-02-09
- 2021-02-11
-
2021-02-12
Survey response — day 7, dose 2MedDRA: Lymphadenopathy — Feeling: GoodFree text: Lymph node swellingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-19
- 2021-02-26
- 2021-03-05
- 2021-03-12
- 2021-03-21
- 2021-05-07
-
2021-08-06
Survey response — 6 months, dose 2MedDRA: Pregnancy — Feeling: GoodFree text: PregnantMedDRA releases: 2021-09,2024-11 · check-in free text available
- 2022-02-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-12 | Pfizer-BioNTech | |
| 2 | 2021-02-05 | Pfizer-BioNTech |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-01-13 | priority 2/3 |
Free text
Release 4 — day 7, dose 2
Systemic reaction (other): Lymph node swelling
Release 9 — 6 months, dose 2
Symptoms: Pregnant
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | ✓ | · | ✓ |
| SRO | Lymphadenopathy | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release